Literature DB >> 20483770

Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.

Nguyen Thi Phuong Dung1, Huynh Thi Le Duyen, Nguyen Thi Van Thuy, Tran Van Ngoc, Nguyen Van Vinh Chau, Tran Tinh Hien, Sarah L Rowland-Jones, Tao Dong, Jeremy Farrar, Bridget Wills, Cameron P Simmons.   

Abstract

Immune activation is a feature of dengue hemorrhagic fever (DHF) and CD8+ T cell responses in particular have been suggested as having a role in the vasculopathy that characterizes this disease. By phenotyping CD8+ T cells (CD38+/HLA-DR+, CD38+/Ki-67+, or HLA-DR+/Ki-67+) in serial blood samples from children with dengue, we found no evidence of increased CD8+ T cell activation prior to the commencement of resolution of viremia or hemoconcentration. Investigations with MHC class I tetramers to detect NS3(133-142)-specific CD8+ T cells in two independent cohorts of children suggested the commencement of hemoconcentration and thrombocytopenia in DHF patients generally begins before the appearance of measurable frequencies of NS3(133-142)-specific CD8+ T cells. The temporal mismatch between the appearance of measurable surface activated or NS3(133-142)-specific CD8+ T cells suggests that these cells are sequestered at sites of infection, have phenotypes not detected by our approach, or that other mechanisms independent of CD8+ T cells are responsible for early triggering of capillary leakage in children with DHF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483770      PMCID: PMC4340505          DOI: 10.4049/jimmunol.0903262

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity.

Authors:  Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

2.  Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock?

Authors:  J Gamble; D Bethell; N P Day; P P Loc; N H Phu; I B Gartside; J F Farrar; N J White
Journal:  Clin Sci (Lond)       Date:  2000-02       Impact factor: 6.124

3.  Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.

Authors:  Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes.

Authors:  Hema S Bashyam; Sharone Green; Alan L Rothman
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

5.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

6.  Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever.

Authors:  D B Bethell; J Gamble; P L Pham; M D Nguyen; T H Tran; T H Ha; T N Tran; T H Dong; I B Gartside; N J White; N P Day
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

Review 7.  Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.

Authors:  I Kurane; A L Rothman; P G Livingston; S Green; S J Gagnon; J Janus; B L Innis; S Nimmannitya; A Nisalak; F A Ennis
Journal:  Arch Virol Suppl       Date:  1994

8.  Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes.

Authors:  Hsin Loke; Delia Bethell; Cao Xuan Thanh Phuong; Nick Day; Nicholas White; Jeremy Farrar; Adrian Hill
Journal:  Am J Trop Med Hyg       Date:  2002-07       Impact factor: 2.345

9.  Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study.

Authors:  Anon Srikiatkhachorn; Anchalee Krautrachue; Warangkana Ratanaprakarn; Lawan Wongtapradit; Narong Nithipanya; Siripen Kalayanarooj; Ananda Nisalak; Stephen J Thomas; Robert V Gibbons; Mammen P Mammen; Daniel H Libraty; Francis A Ennis; Alan L Rothman; Sharone Green
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

10.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

View more
  42 in total

Review 1.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

4.  Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice.

Authors:  Smita Jaiswal; Pamela Pazoles; Marcia Woda; Leonard D Shultz; Dale L Greiner; Michael A Brehm; Anuja Mathew
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

5.  Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.

Authors:  Bobby Brooke Herrera; Wen-Yang Tsai; Charlotte A Chang; Donald J Hamel; Wei-Kung Wang; Yichen Lu; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 6.  Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.

Authors:  Daniela V Andrade; Eva Harris
Journal:  Virus Res       Date:  2017-06-26       Impact factor: 3.303

Review 7.  CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Authors:  Laura Rivino; Mei Qiu Lim
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

8.  Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.

Authors:  Jens Wrammert; Nattawat Onlamoon; Rama S Akondy; Guey C Perng; Korakot Polsrila; Anmol Chandele; Marcin Kwissa; Bali Pulendran; Patrick C Wilson; Orasri Wittawatmongkol; Sutee Yoksan; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Rafi Ahmed
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

9.  Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.

Authors:  Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Sujan Shresta; Alessandro Sette
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.

Authors:  Lalita Priyamvada; Alice Cho; Nattawat Onlamoon; Nai-Ying Zheng; Min Huang; Yevgeniy Kovalenkov; Kulkanya Chokephaibulkit; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Rafi Ahmed; Patrick C Wilson; Jens Wrammert
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.